| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.06e-04 | 51 | 45 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 3.81e-04 | 13 | 45 | 2 | GO:0008046 | |
| GeneOntologyMolecularFunction | phospholipid transporter activity | 6.20e-04 | 74 | 45 | 3 | GO:0005548 | |
| Domain | HnRNP_R/Q_splicing_fac | 4.92e-05 | 5 | 42 | 2 | IPR006535 | |
| Domain | fn3 | 4.72e-04 | 162 | 42 | 4 | PF00041 | |
| Domain | FN3 | 7.77e-04 | 185 | 42 | 4 | SM00060 | |
| Domain | FN3 | 1.02e-03 | 199 | 42 | 4 | PS50853 | |
| Domain | zf-CCHC | 1.21e-03 | 23 | 42 | 2 | PF00098 | |
| Domain | FN3_dom | 1.22e-03 | 209 | 42 | 4 | IPR003961 | |
| Domain | ZF_CCHC | 2.80e-03 | 35 | 42 | 2 | PS50158 | |
| Domain | ZnF_C2HC | 6.80e-03 | 55 | 42 | 2 | SM00343 | |
| Domain | Znf_CCHC | 6.80e-03 | 55 | 42 | 2 | IPR001878 | |
| Domain | Retrov_capsid_C | 7.79e-03 | 59 | 42 | 2 | IPR008916 | |
| Domain | Ig_I-set | 8.89e-03 | 190 | 42 | 3 | IPR013098 | |
| Domain | I-set | 8.89e-03 | 190 | 42 | 3 | PF07679 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.15e-05 | 118 | 25 | 4 | M27316 | |
| Pubmed | Synergistic interaction of MEF2D and Sp1 in activation of the CD14 promoter. | 1.64e-06 | 2 | 45 | 2 | 12213324 | |
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 16886906 | ||
| Pubmed | 4.91e-06 | 3 | 45 | 2 | 22984509 | ||
| Pubmed | Regulation of prion gene expression by transcription factors SP1 and metal transcription factor-1. | 4.91e-06 | 3 | 45 | 2 | 18990686 | |
| Pubmed | Heterogeneous nuclear ribonucleoproteins R and Q accumulate in pathological inclusions in FTLD-FUS. | 4.91e-06 | 3 | 45 | 2 | 30755280 | |
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 11773003 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 18458062 | ||
| Pubmed | 9.81e-06 | 4 | 45 | 2 | 21779326 | ||
| Pubmed | SMN interacts with a novel family of hnRNP and spliceosomal proteins. | 9.81e-06 | 4 | 45 | 2 | 11574476 | |
| Pubmed | Promyelocytic leukemia protein in retinoic acid-induced chromatin remodeling of Oct4 gene promoter. | 3.42e-05 | 7 | 45 | 2 | 21360626 | |
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 12183049 | ||
| Pubmed | 4.56e-05 | 8 | 45 | 2 | 19808671 | ||
| Pubmed | 5.86e-05 | 9 | 45 | 2 | 9738004 | ||
| Pubmed | Parallel Pbx-Dependent Pathways Govern the Coalescence and Fate of Motor Columns. | 5.94e-05 | 58 | 45 | 3 | 27568519 | |
| Pubmed | 7.49e-05 | 808 | 45 | 7 | 20412781 | ||
| Pubmed | 8.94e-05 | 11 | 45 | 2 | 10734137 | ||
| Pubmed | RNF125 attenuates hepatocellular carcinoma progression by downregulating SRSF1-ERK pathway. | 8.94e-05 | 11 | 45 | 2 | 37142680 | |
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 9582278 | ||
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 30658714 | ||
| Pubmed | 1.07e-04 | 12 | 45 | 2 | 16236758 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.25e-04 | 877 | 45 | 7 | 20211142 | |
| Pubmed | 1.27e-04 | 13 | 45 | 2 | 11230134 | ||
| Pubmed | 1.34e-04 | 201 | 45 | 4 | 25192599 | ||
| Pubmed | 1.70e-04 | 15 | 45 | 2 | 24633789 | ||
| Pubmed | 2.06e-04 | 88 | 45 | 3 | 26318153 | ||
| Pubmed | 2.20e-04 | 90 | 45 | 3 | 23151878 | ||
| Pubmed | 2.20e-04 | 90 | 45 | 3 | 31280863 | ||
| Pubmed | 2.20e-04 | 17 | 45 | 2 | 12388589 | ||
| Pubmed | 2.36e-04 | 233 | 45 | 4 | 37704626 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 2.66e-04 | 444 | 45 | 5 | 34795231 | |
| Pubmed | 2.76e-04 | 19 | 45 | 2 | 18711365 | ||
| Pubmed | 2.91e-04 | 709 | 45 | 6 | 22988430 | ||
| Pubmed | Perioperative genomic profiles using structure-specific oligonucleotide probes. | 4.07e-04 | 23 | 45 | 2 | 19474452 | |
| Pubmed | 4.07e-04 | 23 | 45 | 2 | 30470893 | ||
| Pubmed | 4.52e-04 | 115 | 45 | 3 | 17332742 | ||
| Pubmed | 4.70e-04 | 503 | 45 | 5 | 16964243 | ||
| Pubmed | 4.82e-04 | 25 | 45 | 2 | 9731529 | ||
| Pubmed | 5.89e-04 | 126 | 45 | 3 | 16284245 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.70e-04 | 544 | 45 | 5 | 28473536 | |
| Pubmed | Proteomic analysis of complexes formed by human topoisomerase I. | 7.92e-04 | 32 | 45 | 2 | 15848144 | |
| Pubmed | 8.43e-04 | 33 | 45 | 2 | 18193044 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 9.40e-04 | 148 | 45 | 3 | 32538781 | |
| Pubmed | 1.00e-03 | 36 | 45 | 2 | 17289661 | ||
| Pubmed | Telencephalic embryonic subtractive sequences: a unique collection of neurodevelopmental genes. | 1.29e-03 | 165 | 45 | 3 | 16107646 | |
| Interaction | NR4A3 interactions | 1.28e-05 | 69 | 42 | 4 | int:NR4A3 | |
| Cytoband | 9q22.1 | 1.59e-04 | 19 | 45 | 2 | 9q22.1 | |
| Cytoband | 11q12.2 | 6.80e-04 | 39 | 45 | 2 | 11q12.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q14 | 4.12e-03 | 97 | 45 | 2 | chr6q14 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q12 | 4.81e-03 | 105 | 45 | 2 | chr14q12 | |
| GeneFamily | Fibronectin type III domain containing | 1.02e-04 | 160 | 28 | 4 | 555 | |
| GeneFamily | CD molecules|Membrane spanning 4-domains | 3.48e-04 | 18 | 28 | 2 | 958 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.93e-03 | 161 | 28 | 3 | 593 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.82e-02 | 134 | 28 | 2 | 861 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 4.77e-05 | 99 | 43 | 4 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.06e-05 | 330 | 43 | 6 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.80e-05 | 498 | 43 | 7 | gudmap_developingGonad_e11.5_testes_k5_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500 | 1.42e-04 | 50 | 43 | 3 | gudmap_developingGonad_e14.5_ epididymis_500_k1 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_testes_emap-29069_top-relative-expression-ranked_1000 | 2.07e-04 | 819 | 43 | 8 | gudmap_developingGonad_e12.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000 | 2.52e-04 | 843 | 43 | 8 | gudmap_developingGonad_e11.5_testes_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_1000 | 2.54e-04 | 844 | 43 | 8 | gudmap_developingGonad_e11.5_testes and mesonephros_1000 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.24e-06 | 191 | 44 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 1.83e-05 | 159 | 44 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 58 | 44 | 3 | 856be27020dbfa7c1f57bd78840c60f52ca68ed8 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 58 | 44 | 3 | e0cd231f33f5650db4991157cfe4867ccfc774b9 | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Trdn_(Ventral_Globus_Pallidus_Externus_(vGP)_/_Ventral_Pallidum_(VP)_/_magnocellular_preoptic_nucleus_(MCPO))|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 2.59e-05 | 58 | 44 | 3 | 12fecf2fee0dbf5290a7b2389b2cdb0ae00a02b4 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D122|Adult / Lineage, Cell type, age group and donor | 2.72e-05 | 176 | 44 | 4 | 3fee8a367bb9755aca1b7fcc968b08e51b6e9436 | |
| ToppCell | Control|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.78e-05 | 177 | 44 | 4 | b8ff6940e31b749776e81ae4f5bbd577dba9749c | |
| ToppCell | COVID-19-Endothelial_cells-Arterial_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 3.23e-05 | 184 | 44 | 4 | 0f19494789f38ab1a420545e15e748ca7eb345c3 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.30e-05 | 185 | 44 | 4 | e0c9e92e35fb24351f5347a0768e6aab5add8775 | |
| ToppCell | COVID-19-lung-Artery_EC|lung / Disease (COVID-19 only), tissue and cell type | 3.52e-05 | 188 | 44 | 4 | eecd7482b3c97d7f49993cb17edfab30c61232fc | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 190 | 44 | 4 | d0297d678498e346e56cf95fe9e3db7d3ad3b837 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.98e-05 | 194 | 44 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.98e-05 | 194 | 44 | 4 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.98e-05 | 194 | 44 | 4 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.98e-05 | 194 | 44 | 4 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | Control-B_naive-8|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.14e-05 | 196 | 44 | 4 | 54074da84000e4749ade8acc542f05a275bf829f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.14e-05 | 196 | 44 | 4 | 22538376a95fe3afe8639a216a5497087aa94110 | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.39e-05 | 199 | 44 | 4 | fff88d2bba262583bb726900ae01e44954b72eb9 | |
| ToppCell | kidney_cells-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.39e-05 | 199 | 44 | 4 | 5d976d57872a8a25a11fe8cd53b01aa21a1a519a | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 4.39e-05 | 199 | 44 | 4 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.53e-04 | 105 | 44 | 3 | 8f31edf4183587f5b53941475453c5aa49f10bbd | |
| ToppCell | COVID-19_Mild-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 2.38e-04 | 122 | 44 | 3 | 2aa9cfadab70312882ae679e3788fc7ab996c0f3 | |
| ToppCell | LA-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.74e-04 | 128 | 44 | 3 | 071becbe97598c2b65580b0989eb664d6fd6c85a | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-04 | 145 | 44 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Peri/Epineurial_-NAF_endoneurial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.94e-04 | 145 | 44 | 3 | e808502fa52baf1c400f3c9b918a167127e78af9 | |
| ToppCell | Adult-Mesenchymal-chondrocyte-D122|Adult / Lineage, Cell type, age group and donor | 4.18e-04 | 148 | 44 | 3 | 81a1e6fdd942a612bf523c59b8b4974f6ca1fdce | |
| ToppCell | MS-CD4-CD8_1|MS / Condition, Cell_class and T cell subcluster | 4.35e-04 | 150 | 44 | 3 | 7dc95c58b98d8c4c6c49fb1a03ec6ac24fb41f54 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.61e-04 | 153 | 44 | 3 | 1524557514668f515ac1bbe847611f564b265b42 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 4.97e-04 | 157 | 44 | 3 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-Tregs|Lung / Manually curated celltypes from each tissue | 5.06e-04 | 158 | 44 | 3 | f433bc189f000efa34e8e09ab32b3fa22bcf64c4 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.45e-04 | 162 | 44 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 5.45e-04 | 162 | 44 | 3 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 5.54e-04 | 163 | 44 | 3 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-04 | 166 | 44 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.85e-04 | 166 | 44 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell|Adult / Lineage, Cell type, age group and donor | 5.95e-04 | 167 | 44 | 3 | d584a8548a5317bd9686b3be8246ae6ed568796b | |
| ToppCell | facs-Skin-Anagen-24m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-04 | 167 | 44 | 3 | 02c89069dcd0e87f7502e32b14e7cbd3cab81a09 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D231|Adult / Lineage, Cell type, age group and donor | 6.05e-04 | 168 | 44 | 3 | aca34c51758c65925ad24110294a72b2dea6db72 | |
| ToppCell | metastatic_Brain-B_lymphocytes-GrB-secreting_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 6.16e-04 | 169 | 44 | 3 | 71f6761b9927f352e0ccc221ca373319915f4184 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-6_VIP_PENK|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.16e-04 | 169 | 44 | 3 | eb3b8e473192c4b8688f2f8da400116dd6fe193d | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.16e-04 | 169 | 44 | 3 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | CV-Mild-7|CV / Virus stimulation, Condition and Cluster | 6.26e-04 | 170 | 44 | 3 | 25ebde7d2f8ae1afdfaf5876284ff20bb179eb10 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.37e-04 | 171 | 44 | 3 | 1597459c971d6befa991d59dc66b41b6a522f797 | |
| ToppCell | CV-Mild-7|Mild / Virus stimulation, Condition and Cluster | 6.59e-04 | 173 | 44 | 3 | c9bbca9313a0fdf146c8c995624b94b937e818d8 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.81e-04 | 175 | 44 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 6.81e-04 | 175 | 44 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 7.04e-04 | 177 | 44 | 3 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.04e-04 | 177 | 44 | 3 | 8a74f5e72de605774111057bd87a7e7e4a6385cd | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.04e-04 | 177 | 44 | 3 | 1921226196b2ab7919d9f843e60d9f4bd9ec9c57 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.04e-04 | 177 | 44 | 3 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.16e-04 | 178 | 44 | 3 | 73936c2e7e8855b4ab65cad425686513dba331a3 | |
| ToppCell | COPD-Endothelial-VE_Venous|World / Disease state, Lineage and Cell class | 7.27e-04 | 179 | 44 | 3 | 9968da1adcb561d9bf167a42ab5d9de85c071c4a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.39e-04 | 180 | 44 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.51e-04 | 181 | 44 | 3 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.51e-04 | 181 | 44 | 3 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.63e-04 | 182 | 44 | 3 | 86a2330ada7637144a67afbf9f3a902901ab1130 | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 7.75e-04 | 183 | 44 | 3 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 7.88e-04 | 184 | 44 | 3 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | normal-na-Lymphocytic-lymphocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 7.88e-04 | 184 | 44 | 3 | 2c286712428662bc4589dc5ac4011bf7ed403cb5 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.88e-04 | 184 | 44 | 3 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 7.88e-04 | 184 | 44 | 3 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Adult / Lineage, Cell type, age group and donor | 8.00e-04 | 185 | 44 | 3 | 673f0c688ae6984bc8027df2da335787924f4137 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Stalk-like_ECs|metastatic_Brain / Location, Cell class and cell subclass | 8.00e-04 | 185 | 44 | 3 | ad52970e88e8947ef256095bd4b40229b912d58a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.00e-04 | 185 | 44 | 3 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.00e-04 | 185 | 44 | 3 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 186 | 44 | 3 | 2e024097ee361eeb1d855a4edb8ac8cdad35da06 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.13e-04 | 186 | 44 | 3 | c3449e54454009973818fc1101933c6f0168258c | |
| ToppCell | COPD-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 8.25e-04 | 187 | 44 | 3 | be42ee71d3412bb1f52593d8814de85c354a0efa | |
| ToppCell | Control-Endothelial_cells-Endothelial_cells_(general)|Control / group, cell type (main and fine annotations) | 8.25e-04 | 187 | 44 | 3 | fb5bcbc8effdbf0e57fcb71aca990a4aa0d65ce8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.25e-04 | 187 | 44 | 3 | e35716f8b482be3bf5ab79f087a9caf67a9d197a | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|Mesenchymal_cells / Lineage and Cell class | 8.25e-04 | 187 | 44 | 3 | e899b906409f3fad69cb3d3c6432c3fd862ae3c1 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B0|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 8.25e-04 | 187 | 44 | 3 | 816d37a70f7ec382a268fe828b3dfe737a36a4bf | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 8.25e-04 | 187 | 44 | 3 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.25e-04 | 187 | 44 | 3 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.38e-04 | 188 | 44 | 3 | 117dc80fa940e6aa1b0187a43fdde33f3fcb578f | |
| ToppCell | Control-Endothelial_cells|Control / group, cell type (main and fine annotations) | 8.38e-04 | 188 | 44 | 3 | 3953b08abfea93468fc8d177bdb16ca7c6ffa1ab | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.51e-04 | 189 | 44 | 3 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.51e-04 | 189 | 44 | 3 | e60a3d6aa84788c29f23439f1c747431ea581bc3 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.64e-04 | 190 | 44 | 3 | 5130fb325f80f591b9b36beacb8072c4472304f2 | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 8.64e-04 | 190 | 44 | 3 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.64e-04 | 190 | 44 | 3 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 8.64e-04 | 190 | 44 | 3 | 7f3f419fffe02934b6f27b697f7a6401072491ed | |
| ToppCell | PCW_13-14|World / Celltypes from embryonic and fetal-stage human lung | 8.64e-04 | 190 | 44 | 3 | 62a3ec1ae0829602b0569cc051210551644f1d46 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.64e-04 | 190 | 44 | 3 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.64e-04 | 190 | 44 | 3 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.64e-04 | 190 | 44 | 3 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | PND01-03-samps-Endothelial|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.64e-04 | 190 | 44 | 3 | 1357bd4527399d7013ee33272bda7453f472999a | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.64e-04 | 190 | 44 | 3 | 2803eb02209591a63fe13e834e4e0f8014e1aa34 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.64e-04 | 190 | 44 | 3 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | Control-Endothelial-VE_Capillary_B|Control / Disease state, Lineage and Cell class | 8.77e-04 | 191 | 44 | 3 | 322237793a1278bafb14e63cab688b353e352dcc | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.77e-04 | 191 | 44 | 3 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.77e-04 | 191 | 44 | 3 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | PND01-Endothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.77e-04 | 191 | 44 | 3 | 96b9b0aaf0cb2d6f929ff563dbaedc83ffb4795e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.77e-04 | 191 | 44 | 3 | a0332a4ef629510fb313ec119195c44a3f704a80 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | 9c5d88f0d3c834c2419ec3da74652175153ba9df | |
| ToppCell | Control-Endothelial-VE_Capillary_B|World / Disease state, Lineage and Cell class | 8.77e-04 | 191 | 44 | 3 | c672c8e28d06d555335976b3f8bd2ea6d3b34aae | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | a7494191a92984e5f53610bbbedd6714e9169e1c | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.77e-04 | 191 | 44 | 3 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.91e-04 | 192 | 44 | 3 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| Disease | coiled-coil domain-containing protein 126 measurement | 4.13e-05 | 7 | 42 | 2 | EFO_0801482 | |
| Disease | ceramide measurement | 3.46e-04 | 235 | 42 | 4 | EFO_0010222 | |
| Disease | Colorectal Carcinoma | 4.49e-04 | 702 | 42 | 6 | C0009402 | |
| Disease | Kallmann Syndrome | 6.29e-04 | 26 | 42 | 2 | C0162809 | |
| Disease | Barrett's esophagus | 7.30e-04 | 28 | 42 | 2 | EFO_0000280 | |
| Disease | gas trapping measurement | 7.84e-04 | 29 | 42 | 2 | EFO_0007628 | |
| Disease | progressive supranuclear palsy | 8.96e-04 | 31 | 42 | 2 | MONDO_0019037 | |
| Disease | hypospadias | 1.42e-03 | 39 | 42 | 2 | EFO_0004209 | |
| Disease | white matter microstructure measurement | 2.26e-03 | 390 | 42 | 4 | EFO_0005674 | |
| Disease | brain connectivity measurement | 2.48e-03 | 400 | 42 | 4 | EFO_0005210 | |
| Disease | TPE interval measurement | 2.51e-03 | 52 | 42 | 2 | EFO_0004644 | |
| Disease | left ventricular diastolic function measurement | 2.70e-03 | 54 | 42 | 2 | EFO_0008204 | |
| Disease | triglycerides in very large HDL measurement | 2.80e-03 | 55 | 42 | 2 | EFO_0022324 | |
| Disease | Seizures | 3.69e-03 | 218 | 42 | 3 | C0036572 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPLNQTALQVSWSQP | 356 | P23470 | |
| GNPNETQNNSTSWPV | 506 | P06276 | |
| QQAWQQPGNPYSSSQ | 81 | A8MQ03 | |
| TLPWVQGIICNANNP | 66 | O95477 | |
| QNLSNNNLIPAPNWQ | 86 | Q9Y2F9 | |
| QPPQWLQTLMNACSQ | 786 | Q5JWR5 | |
| QLNQSQVAWTGSRPP | 566 | Q9HBZ2 | |
| PLQELPNQASNWSAG | 191 | Q6IWH7 | |
| PQSPRPQSWAAANQT | 26 | Q8N907 | |
| VGGASNWISNLPNNS | 101 | Q5VYY2 | |
| GGTQQILLPSTWQQL | 751 | Q86Z02 | |
| QASGSPVPTIQWLQN | 1741 | Q8NDA2 | |
| LGNNSPWNSKPPATQ | 346 | O43679 | |
| NNQNWGSQPIAQQPL | 581 | O60506 | |
| SLPASSNPGNQAWQL | 26 | A0PG75 | |
| SNPGNQAWQLSLPLP | 31 | A0PG75 | |
| QQNWGSQPIAQQPLQ | 591 | O43390 | |
| VLSPVQPWQTSAPQN | 21 | Q96PG2 | |
| NSWIPPFSGILQQQQ | 51 | A1E959 | |
| QGQNQTWNRPSIAPN | 126 | Q96KD3 | |
| LQSQAQGSWQGATPQ | 341 | Q9BYU1 | |
| LGTGPNWSTINQQSV | 396 | Q9HDB9 | |
| WPSAQSQLQSQLPQN | 321 | A0A1W2PPK0 | |
| NLQTWPGDLQNPLNA | 106 | Q3C1V0 | |
| LNTQITQWVGPTNGN | 191 | Q9Y3B6 | |
| TWNAPSPQFINGINQ | 811 | Q58EX2 | |
| QANVNTWNLVSPDSP | 1031 | P42702 | |
| LSLGNVTAWQQPQQP | 356 | Q14814 | |
| APTAPQNSQLTWKQG | 161 | Q13033 | |
| LQSNITQCLLGQPWP | 1291 | Q13428 | |
| NLQWILNGATSSPQN | 571 | Q14872 | |
| NTQQIPPQAWPAAVS | 426 | Q92529 | |
| TTLNPFWNVSTQPQQ | 401 | Q6ZUB1 | |
| SQIQTPNPNQDQWSG | 506 | Q02383 | |
| VGPNGQVSWQTLQLQ | 456 | P08047 | |
| APSQPWANLTNQFVQ | 66 | P29371 | |
| PLNSWQGANTVGSIQ | 616 | Q15468 | |
| AWGQPSIQSSVQQGL | 31 | C9J3V5 | |
| LQASGQPSLQSQWQP | 326 | Q96S82 | |
| QPSLQSQWQPQLQQL | 331 | Q96S82 | |
| QSKFGLPQAQQPQWS | 406 | Q8IYB5 | |
| LPQAQQPQWSLSQMN | 411 | Q8IYB5 | |
| PQKNNGSTWANVPLP | 1061 | Q9HCK4 | |
| NNWSPPVQSNETANG | 2441 | O00507 | |
| PANQTWGQGSSLQKN | 31 | Q9P0L1 | |
| PLSLNAPKGLWSQNQ | 296 | Q9Y2Y4 | |
| IPPWQQQQAAAAASP | 541 | Q15637 | |
| VPWQQNTNQPPGSLS | 151 | Q9ULJ6 | |
| WGVTNTSQSQVLGNP | 171 | Q9ULJ6 |